Biogened S.A.

WSE:BGD Voorraadrapport

Marktkapitalisatie: zł54.0m

Biogened Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Andrzej Grzegorzewski

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur10.8yrs

Recente managementupdates

Recent updates

Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

Nov 06
Biogened (WSE:BGD) Takes On Some Risk With Its Use Of Debt

A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Aug 28
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Aug 22
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

CEO

Andrzej Grzegorzewski (54 yo)

no data

Tenure

Mr. Andrzej Grzegorzewski serves as the President of the Management Board at Biogened S.A. Mr. Grzegorzewski served as the President of the Management Board and General Director at Miraculum Spolka Akcyjna...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Anna Kowalska
Member of the Supervisory Board12.4yrsgeen gegevensgeen gegevens
Urszula Grzegorzewska
Chairman of the Supervisory Board 13.8yrsgeen gegevensgeen gegevens
Sylwia Grzegorzewska
Member of the Supervisory Board3.7yrsgeen gegevensgeen gegevens
Andrzej Mozyszek
Member of the Supervisory Board12.4yrsgeen gegevensgeen gegevens
Elzbieta Mikolajczak
Member of the Supervisory Board10.8yrsgeen gegevensgeen gegevens
Sebastian Kostecki
Member of the Supervisory Board10.8yrsgeen gegevensgeen gegevens
Marek Mikolajczak
Member of the Supervisory Board3.7yrsgeen gegevensgeen gegevens

10.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van BGD zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.8 jaar).